Hirsch M, Berg L, Gamaleldin I, Vyas S, Vashisht A
Elizabeth Garrett Anderson Institute for Women's Health, University College London, United Kingdom.
Women's Health, Southmead Hospital, Bristol, United Kingdom.
Facts Views Vis Obgyn. 2021 Jan 8;12(4):291-298.
This study evaluates current national opinions on screening, diagnosis, and management of thoracic endometriosis.
Thoracic endometriosis is a rare but serious condition with four main clinical presentations: pneumothorax, haemoptysis, haemothorax, and pulmonary nodules. There are no specialist centres in the United Kingdom despite growing patient desire for recognition, investigation, and treatment.
We distributed a multiple-choice email survey to senior members of the British Society for Gynaecological Endoscopy. Descriptive statistics were used to present the results. Results: We received 67 responses from experienced clinicians having provided over 800 combined years of endometriosis patient care. The majority of respondents managed over 100 endometriosis patients annually, for more than five years. Over one third had never managed a patient with symptomatic thoracic endometriosis; just 9% had managed more than 30 cases over the course of their career. Screening varied by modality with only 4% of clinicians always taking a history of respiratory symptoms while 69% would always screen for diaphragmatic endometriosis during laparoscopy. The management of symptomatic thoracic endometriosis varied widely with the commonest treatment being surgery followed by hormonal therapies. Regarding management, 71% of respondents felt the team should comprise of four or more different specialists, and 56% believed care should be centralised either regionally or nationally.
Thoracic endometriosis is poorly screened for amongst clinicians with varied management lacking a common diagnostic or therapeutic pathway in the United Kingdom. Specialists expressed a preference for women to be managed in a large multidisciplinary team setting at a regional or national level.
本研究评估了目前国内对胸腔子宫内膜异位症筛查、诊断及管理的看法。
胸腔子宫内膜异位症是一种罕见但严重的疾病,有四种主要临床表现:气胸、咯血、血胸和肺结节。尽管患者对其识别、检查和治疗的需求不断增加,但英国尚无专科中心。
我们向英国妇科内镜学会的资深成员发送了一份多项选择电子邮件调查问卷。采用描述性统计方法呈现结果。
我们收到了67份回复,这些经验丰富的临床医生累计提供了800多年的子宫内膜异位症患者护理服务。大多数受访者每年管理100多名子宫内膜异位症患者,且持续时间超过五年。超过三分之一的受访者从未管理过有症状的胸腔子宫内膜异位症患者;在其职业生涯中,只有9%的人管理过30多例此类病例。筛查方式各不相同,只有4%的临床医生总是询问呼吸症状病史,而69%的临床医生在腹腔镜检查时总会筛查膈肌子宫内膜异位症。有症状的胸腔子宫内膜异位症的管理方式差异很大,最常见的治疗方法是手术,其次是激素治疗。关于管理,71%的受访者认为团队应由四名或更多不同专科的医生组成,56%的人认为护理应在地区或全国范围内集中进行。
在英国,临床医生对胸腔子宫内膜异位症的筛查不足,管理方式多样,缺乏共同的诊断或治疗途径。专家们表示倾向于在地区或国家层面的大型多学科团队环境中对患者进行管理。